Sands Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-65,744
Closed -$5.87M 70
2018
Q1
$5.87M Buy
65,744
+21,825
+50% +$2.1M 0.02% 62
2017
Q4
$4.58M Buy
43,919
+39,789
+963% +$4.49M 0.01% 63
2017
Q3
$602K Buy
+4,130
New +$563K ﹤0.01% 67

Other funds holding CELG

Sands Capital Management's CELG Position: Q2 2018 in Review

Sands Capital Management sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 65,744 shares — an estimated $5.87M sold.

Sands Capital Management first reported a position in CELG in Q3 2017 and held it in 3 quarters. The position peaked at $5.87M in Q1 2018. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Sands Capital Management reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Sands Capital Management sold 65,744 Celgene Corp shares in Q2 2018, an estimated $5.87M.
  • Sands Capital Management first reported a position in Celgene Corp in Q3 2017 and held it in 3 quarters.
  • Sands Capital Management's Celgene Corp position peaked at $5.87M in Q1 2018.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Sands Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.